Application for Clinical Trials
Product Details
Title of Study: Assessing Response to neo-adjuvant Taxotere and Trastuzumab in Nigerian women with HER2-positive breast cancer
Subtitle: ARTETTA
Protocol; Version: CABC123D4567; 1
Phase of Study: Phase 3;
Study Type: industry sponsor
Approval Date:
Applicant Name: Prof. (Mrs) Peace Babalola
Address: Pharmacy Department, University College Hospital Ibadan
Date of Application: 2019-07-17
Applicant Name: Prof. (Mrs) Peace Babalola
Sponsor: University of Chicago, Bilogical Science Division/University of Chicago Medical Center
Address of Sponsor: University of Chicago Center for Global Health (UC CGH), 60637 Chicago, USA
Trial Sites: 1. Lagos State University Teaching Hospital, Ikeja, Lagos State 2. Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) Ile Ife 3. Lagos University Teaching Hospital LUTH 4. University College Hospital, Ibadan
Product Type: Drug
Status of Approval: on-going
You are trying to load a table of an unknown type. Probably you did not activate the addon which is required to use this table type.